By Emon Reiser
Haemonetics appointed Dr. Frank Chan, a longtime Medtronic executive, as vice president and chief operating officer, effective April 7.
The Boston-based blood collection and transfusion services company on Monday said Chan has more than 25 years of experience in the medical device and healthcare technology sectors. He was recently president of acute care and monitoring at Medtronic, where he has held leadership positions since 2015. Chan will report to Haemonetics Chief Executive Officer Chris Simon.
Haemonetics also promoted Roy Galvin, currently president of the company's global plasma and blood center, to chief commercial officer, effective immediately. His expanded role gives him responsibility over the company's global hospital business, and its global plasma and blood center business. Stewart Strong will continue in his role as president of global hospital for Haemonetics until April 1, and then transition to become an adviser to the CEO for a temporary period.
Write to Emon Reiser at emon.reiser@wsj.com
(END) Dow Jones Newswires
March 03, 2025 18:01 ET (23:01 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.